机构名称：
¥ 3.0
• Develops multi-target therapies using Brazilian biodiversity as a platform • Applies proprietary technologies like xGIbiomics® and GAIApath® to simulate the digestive system, its microbiota, and map medicinal plants with therapeutic potential • Established strategic partnerships with CNPEM and CIENP to expand its research • Raised funds from multiple sources, including FINEP, FAPESP, Pitanga和MaraéInvestimentos•由Life Sciences评论评为拉丁美洲十大生物技术初创公司之一
驾驶LATAM的全球足迹2024年11月
主要关键词
相关文件推荐
